Search research articles
Contact Us
Filters
Showing results (881-890 of 920) with videos related to
Page
of 92
Sort By:
Journal of Medicinal Chemistry
|
April 29, 2025
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9
Matthew H Daniels, Jennifer Castro, Young-Tae Lee, et al.
Molecular Cancer Therapeutics
|
August 24, 2019
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
Huai-Xiang Hao, Hongyun Wang, Chen Liu, et al.
Cancer Discovery
|
April 18, 2020
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Defne Bayik, Yadi Zhou, Chihyun Park, et al.
Stem Cells (Dayton, Ohio)
|
May 5, 2016
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
Balint Otvos, Daniel J Silver, Erin E Mulkearns-Hubert, et al.
Cancer Discovery
|
June 28, 2023
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma
Juyeun Lee, Michael Nicosia, Ellen S Hong, et al.
Communications Biology
|
April 9, 2025
Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitor
Gordon J Lockbaum, Maureen M Lynes, Sophie A Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2016
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
Roman Reinartz, Shanshan Wang, Sied Kebir, et al.
Nature Methods
|
June 28, 2011
A public genome-scale lentiviral expression library of human ORFs
Xiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Science Translational Medicine
|
July 19, 2023
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment
Lara Lechner, Robert Opitz, Matt J Silver, et al.
Cancer Research
|
September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma
Julie A Shields, Samuel R Meier, Madhavi Bandi, et al.
Page
of 92
Search research articles
Search
Showing results (881-890 of 920) with videos related to
Sort By:
Page
of 92
Journal of Medicinal Chemistry
|
April 29, 2025
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9
Matthew H Daniels, Jennifer Castro, Young-Tae Lee, et al.
Molecular Cancer Therapeutics
|
August 24, 2019
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers
Huai-Xiang Hao, Hongyun Wang, Chen Liu, et al.
Cancer Discovery
|
April 18, 2020
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Defne Bayik, Yadi Zhou, Chihyun Park, et al.
Stem Cells (Dayton, Ohio)
|
May 5, 2016
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
Balint Otvos, Daniel J Silver, Erin E Mulkearns-Hubert, et al.
Cancer Discovery
|
June 28, 2023
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma
Juyeun Lee, Michael Nicosia, Ellen S Hong, et al.
Communications Biology
|
April 9, 2025
Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitor
Gordon J Lockbaum, Maureen M Lynes, Sophie A Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2016
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
Roman Reinartz, Shanshan Wang, Sied Kebir, et al.
Nature Methods
|
June 28, 2011
A public genome-scale lentiviral expression library of human ORFs
Xiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Science Translational Medicine
|
July 19, 2023
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment
Lara Lechner, Robert Opitz, Matt J Silver, et al.
Cancer Research
|
September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma
Julie A Shields, Samuel R Meier, Madhavi Bandi, et al.
Page
of 92